Spruce Biosciences, Inc. (SPRB) NASDAQ
49.30
-1.4(-2.76%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
49.30
-1.4(-2.76%)
Currency In USD
| Market Cap | 66.78M |
| Enterprise Value | 18.61M |
| P/E Ratio | -1.82 |
| PEG Ratio | -0.02 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.95 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.66 |
| Return On Equity | -1.55 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -38.85M |
| Net Income | -38.97M |
| Diluted EPS | -50.83 |
| Total Cash | 54.08M |
| Total Cash/Share | 39.41 |
| Total Debt | 7.12M |
| Total Debt/Equity | 0.21 |
| Current Ratio | 4.67 |
| Book Value Per Share | 25.25 |
| 52-Week Change | 927.08 |
| 52-Week High | 838.13 |
| 52-Week Low | 7 |
| Moving Average 50 Days | 58.83 |
| Moving Average 200 Days | 69.18 |
| Average Volume | 61,509 |
| Shares Outstanding | 1.37M |
| % Held by Institutions | 96.5 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:75 |
| Last Split Date | August 05, 2025 |